Osteopenia and Attention deficit hyperactivity disorder
Summary:
Attention deficit hyperactivity disorder is found among people with Osteopenia, especially for people who are female, 40-49 old.
The study analyzes which people have Attention deficit hyperactivity disorder with Osteopenia. It is created by eHealthMe based on reports of 44 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Osteopenia?
Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,437 drugs and 1,172 conditions by eHealthMe. Check the latest studies of Osteopenia.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 608 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
44 people who have Osteopenia and Attention Deficit Hyperactivity Disorder are studied.

Gender of people who have Osteopenia and experienced Attention Deficit Hyperactivity Disorder *:
- female: 95 %
- male: 5 %
Age of people who have Osteopenia and experienced Attention Deficit Hyperactivity Disorder *:
- 0-1: 0.0 %
- 2-9: 2.63 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 42.11 %
- 50-59: 39.47 %
- 60+: 15.79 %
Common co-existing conditions for these people *:
- Osteoporosis (bones weak and more likely to break): 24 people, 54.55%
- Breast Cancer: 7 people, 15.91%
- Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 5 people, 11.36%
- Sleep Disorder: 1 person, 2.27%
- Pain: 1 person, 2.27%
- Impulsive Behavior: 1 person, 2.27%
- Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 2.27%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 2.27%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.27%
- Diabetes: 1 person, 2.27%
Common drugs taken by these people *:
- Fosamax: 43 people, 97.73%
- Boniva: 15 people, 34.09%
- Alendronate Sodium: 12 people, 27.27%
- Tamoxifen Citrate: 7 people, 15.91%
- Synthroid: 6 people, 13.64%
- Bupropion Hydrochloride: 5 people, 11.36%
- Colace: 5 people, 11.36%
- Enoxaparin Sodium: 5 people, 11.36%
- Vitamins: 5 people, 11.36%
- Sertraline Hydrochloride: 5 people, 11.36%
Common symptoms for these people *:
- Fall: 34 people, 77.27%
- Fatigue (feeling of tiredness): 29 people, 65.91%
- Stress And Anxiety: 26 people, 59.09%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 26 people, 59.09%
- Muscle Spasms (muscle contraction): 24 people, 54.55%
- Foot Fracture: 24 people, 54.55%
- Head Injury: 21 people, 47.73%
- Depression: 21 people, 47.73%
- Arthropathy: 20 people, 45.45%
- Back Pain: 20 people, 45.45%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Attention deficit hyperactivity disorder?
- Check whether Attention deficit hyperactivity disorder is associated with a drug or a conditionRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Osteopenia (46,948 reports)
- Attention deficit hyperactivity disorder (120,340 reports)
All the drugs that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (608 drugs)
All the conditions that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (1,395 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Attention deficit hyperactivity disorder and Osteopenia, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Retinal Detachment and drugs of ingredients of exemestane - a second ago
- Isoniazid and Folic Acid drug interactions for women aged 30-39 - 5 seconds ago
- Blister and drugs of ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - 5 seconds ago
- Intussusception and drugs of ingredients of furosemide - 6 seconds ago
- Insomnia Exacerbated and drugs of ingredients of fenoterol hydrobromide - 6 seconds ago
- Vyvanse vs. Amphetamine Sulfate, side effect and effectiveness comparison - 7 seconds ago
- Enbrel vs. Omeprazole, side effect and effectiveness comparison - 7 seconds ago
- Fentanyl-100 vs. Methotrexate, side effect and effectiveness comparison - 8 seconds ago
- Drug interactions of Ditropan Xl and Lopurin - 10 seconds ago
- Burning Mouth Syndrome and drugs of ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - 10 seconds ago